You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Title |
Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil
|
---|---|
Published by |
Cambridge University Press (CUP), January 2021
|
DOI | 10.1111/j.1748-720x.2012.00698.x |
Pubmed ID | |
Authors |
Lucija Tomljenovic, Christopher A. Shaw |
X Demographics
The data shown below were collected from the profiles of 76 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 11 | 14% |
Canada | 5 | 7% |
India | 3 | 4% |
Australia | 2 | 3% |
Portugal | 1 | 1% |
United Kingdom | 1 | 1% |
Netherlands | 1 | 1% |
Unknown | 52 | 68% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 68 | 89% |
Practitioners (doctors, other healthcare professionals) | 6 | 8% |
Scientists | 1 | 1% |
Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Turkey | 1 | <1% |
Canada | 1 | <1% |
Unknown | 100 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 22 | 21% |
Student > Master | 16 | 15% |
Researcher | 14 | 13% |
Student > Ph. D. Student | 11 | 11% |
Student > Doctoral Student | 7 | 7% |
Other | 14 | 13% |
Unknown | 20 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 27 | 26% |
Agricultural and Biological Sciences | 14 | 13% |
Nursing and Health Professions | 11 | 11% |
Social Sciences | 10 | 10% |
Biochemistry, Genetics and Molecular Biology | 6 | 6% |
Other | 13 | 13% |
Unknown | 23 | 22% |